Questions and Concerns About HPV Vaccine: A Communication Experiment.

Autor:	Shah PD; Public Health Sciences Division, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington; pshah@fredhutch.org.; Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, North Carolina., Calo WA; Department of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania.; Penn State Cancer Institute, Hershey, Pennsylvania; and., Gilkey MB; Department of Health Behavior, Gillings School of Global Public Health.; Lineberger Comprehensive Cancer Center, School of Medicine, and., Boynton MH; Department of Health Behavior, Gillings School of Global Public Health.; Lineberger Comprehensive Cancer Center, School of Medicine, and., Alton Dailey S; Department of Health Behavior, Gillings School of Global Public Health., Todd KG; Public Health Leadership Program and.; SAFEchild Advocacy Center, Raleigh, North Carolina., Robichaud MO; Department of Health Behavior, Gillings School of Global Public Health., Margolis MA; Department of Health Behavior, Gillings School of Global Public Health., Brewer NT; Department of Health Behavior, Gillings School of Global Public Health.; Lineberger Comprehensive Cancer Center, School of Medicine, and.
Jazyk:	angličtina
Zdroj:	Pediatrics [Pediatrics] 2019 Feb; Vol. 143 (2). Date of Electronic Publication: 2019 Jan 22.
DOI:	10.1542/peds.2018-1872
Abstrakt:	: media-1vid110.1542/5972295740001PEDS-VA_2018-1872 Video Abstract OBJECTIVES: We sought to identify effective responses to parents' questions and concerns about human papillomavirus (HPV) vaccine. Methods: In 2017-2018, we surveyed a national sample of 1196 US parents of children aged 9 to 17 years. We recorded brief videos of a pediatrician providing messages that addressed 7 HPV vaccination topics that commonly elicit questions or concerns (eg, recommended age). We randomly assigned parents to 1 of the message topics; parents then viewed 4 videos on that topic in random order and evaluated the messages. Results: Parents were more confident in HPV vaccine when they were exposed to messages that addressed lack of knowledge about HPV vaccine ( b = 0.13; P = .01), messages that included information about cancer prevention ( b = 0.11; P < .001), messages that required a higher reading level ( b = 0.02; P = .01), and messages that were longer ( b = 0.03; P < .001). Parents were less confident in HPV vaccine when exposed to messages in which urgency was expressed ( b = -0.06; P = .005). Analyses conducted by using HPV vaccine motivation as an outcome revealed the same pattern of findings. Conclusions: We provide research-tested messages that providers can use to address parents' HPV vaccination questions and concerns about 7 common topics. Important principles for increasing message effectiveness are to include information on the benefits of vaccination (including cancer prevention) and avoid expressing urgency to vaccinate when addressing parents' questions or concerns. Additionally, providers may need to be prepared to have longer conversations with parents who express concerns about HPV vaccine, especially regarding safety and side effects. Competing Interests: POTENTIAL CONFLICT OF INTEREST: Dr Brewer has served on paid advisory boards of and received research grants from Merck, Pfizer, and GlaxoSmithKline; the other authors have indicated they have no potential conflicts of interest to disclose. (Copyright © 2019 by the American Academy of Pediatrics.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu